Pilot Study of Percutaneous Correction of Hallux Valgus
hallux valgus
1 other identifier
interventional
40
1 country
1
Brief Summary
This is a pilot study with a randomized controlled design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 22, 2022
CompletedFirst Submitted
Initial submission to the registry
February 1, 2023
CompletedFirst Posted
Study publicly available on registry
May 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
May 4, 2026
April 1, 2026
4.9 years
February 1, 2023
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Visual Analog Score
pain visual analog assessment
baseline
Visual Analog Score
pain visual analog assessment
1 year
Secondary Outcomes (1)
American Orhtopaedic Foot and Ankle Society forefoot score
baseline and aftef 1 year
Study Arms (2)
standard treatment
ACTIVE COMPARATORSERI osteotomy
experimental treatment
EXPERIMENTALpercutaneous osteotomy according to Chevron
Interventions
Correction of varus deformity of the 1st Metatarsal that is stabilized with Kirschnner wire
Correction of varus deformity by osteotomy stabilization with 2 screws inserted via dorsal percutaneous accesses to the 1st Metatarsal.
Eligibility Criteria
You may qualify if:
- Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment
- HVA (hallux valgus angle): 20°-40°
- IMA (intermetatarsal angle): 10°-20°
You may not qualify if:
- Patients with instability of the first metatarsophalangeal joint
- Patients with severe morphostructural alterations or other pathologies in the foot and lower limb
- patients requiring additional surgical procedures
- patients with severe vascular and neurological systemic pathologies
- systemic pathologies that may impair bone consolidation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istituto Ortopedico Rizzoli
Bologna, 40136, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2023
First Posted
May 30, 2023
Study Start
February 22, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04